|
End-of-day quote
Canadian Securities Exchange
04/09/2026
|
5-day change | 1st Jan Change | ||
| 0.0300 CAD | 0.00% |
|
0.00% | -60.00% |
| Market Cap | 39.22L 28.35L 24.39L 22.95L 20.96L 27Cr 39.33L 2.71Cr 1.05Cr 14Cr 1.06Cr 1.04Cr 44Cr | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 54.27L 39.23L 33.76L 31.76L 29.01L 37Cr 54.42L 3.75Cr 1.46Cr 19Cr 1.47Cr 1.44Cr 61Cr | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
85.31% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| HERB | End-of-day quote | |
Canadian Securities Exchange
| HERB | Delayed | |
|
OTC Markets
| LUFFF | Delayed | |
|
Deutsche Boerse AG
| HA9 | Delayed |
| 1 month | -25.00% | ||
| 3 months | -50.00% | ||
| 6 months | -45.45% | ||
| Current year | -60.00% |
| 1 week | 0.02 |  | 0.04 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.12 |
| 1 year | 0.02 | | 0.13 |
| 3 years | 0.02 | | 0.13 |
| 5 years | 0.02 | | 0.25 |
| 10 years | 0.02 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 15/05/2020 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 18/01/2022 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 15/05/2020 |
Drew Malcolm
BRD | Director/Board Member | - | 24/06/2020 |
Herb Dhaliwal
CHM | Chairman | 73 | 23/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/07/26 | Option | Executive/Senior Manager | -1,00,000 | 0.0779% | ||
| 02/07/26 | Option | Founder | 1,20,000 | 0.0935% | ||
| 02/07/26 | Option | Chairman | -50,000 | 0.0389% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -50.00% | -70.00% | 28.35L | |
| +0.49% | +2.04% | -13.96% | -6.39% | 1.36TCr | |
| +1.17% | -1.39% | -31.21% | -56.47% | 493.14Cr | |
| +2.06% | -1.16% | -1.26% | -3.48% | 461.52Cr | |
| +0.95% | -1.92% | -3.17% | -30.82% | 394.93Cr | |
| -0.06% | -1.29% | -21.67% | +1.64% | 356.76Cr | |
| +0.82% | +2.75% | +0.08% | -0.77% | 353.37Cr | |
| +0.34% | -1.07% | -10.18% | +5.44% | 327.78Cr | |
| 0.00% | -2.11% | -22.33% | -16.15% | 233.26Cr | |
| -0.20% | -2.69% | -27.64% | -16.84% | 168.03Cr | |
| Average | +0.56% | +0.19% | -18.13% | -19.38% | 414.5Cr | |
| Weighted average by Cap. | +0.70% | +0.61% | -13.77% | -13.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 99.23L 71.73L 61.72L 58.07L 53.05L 68Cr 99.51L 6.86Cr 2.66Cr 35Cr 2.69Cr 2.63Cr 111.93Cr | 1.21Cr 87.63L 75.41L 70.95L 64.81L 83Cr 1.22Cr 8.38Cr 3.25Cr 42Cr 3.29Cr 3.22Cr 136.75Cr |
| Net income | -27.73L -20.04L -17.25L -16.23L -14.82L -19Cr -27.81L -1.92Cr -74.41L -9.71Cr -75.26L -73.62L -31Cr | -18.41L -13.31L -11.45L -10.78L -10L -13Cr -18.46L -1.27Cr -49.41L -6.45Cr -49.98L -48.89L -21Cr |
| Net Debt | 13.75L 10L 9L 8L 7L 9.38Cr 13.79L 95.07L 36.89L 4.81Cr 37.32L 36.5L 16Cr | 15.05L 10.88L 9L 9L 8L 10Cr 15.1L 1.04Cr 40.4L 5.27Cr 40.86L 39.97L 17Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | CA$0.0300 | 0.00% | 73,350 |
| 03/26/03 | CA$0.0300 | 0.00% | 64,857 |
| 02/26/02 | CA$0.0300 | +20.00% | 45,610 |
| 01/26/01 | CA$0.0250 | -16.67% | 1,59,032 |
| 31/26/31 | CA$0.0300 | 0.00% | 16,156 |
- Stock Market
- Stocks
- HERB Stock
Select your edition
All financial news and data tailored to specific country editions
